
|Videos|November 14, 2022
Dr. Meeks recaps LUGPA panel on optimizing advanced bladder cancer clinic
Author(s)Urology Times staff
"There's 3000 patient trials that are either done or going to be done within the next year or 2 in the BCG-naïve setting, and all of them have systemic therapy," says Joshua J. Meeks, MD, PhD.
Advertisement
Joshua J. Meeks, MD, PhD, is an associate professor of urology at the Northwestern University Feinberg School of Medicine in Chicago, Illinois. In this interview, Meeks recaps a panel discussion on ABCC optimization, which took place at the
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Matthew Truesdale, MD, on IsoPSA performance with and without mpMRI
2
Published VAPOR 2 data evaluate water vapor ablation for localized prostate cancer
3
Treatment Intensification in Metastatic Castration-Sensitive Prostate Cancer
4
The UroOnc Minute: Making Appointments More Effective, With David Canes, MD
5












